Atrial fibrillation in chronic kidney disease - treatment standard
The prevalence of atrial fibrillation (AF) is high among patients with chronic kidney disease (CKD). While patients with CKD Stages G1 - G3b may be treated similarly to patients without CKD, little evidence guides therapeutic strategies for CKD G4 - G5 patients. Dosing of most drugs used for rate and rhythm control requires adjustment to kidney function. Recurrence rates after cardioversion and ablation for rhythm control are higher in patients with advanced CKD than those without it. Regarding the prevention of stroke and systemic embolism, the benefit-to-risk ratio of oral anticoagulation (OAC) is disputed among patients with CKD stages G4 - G5 with AF, in particular among those receiving hemodialysis given their high risk for severe bleeding events. Novel strategies for stroke and systemic embolism prevention, particularly factor XI inhibitors and left atrial appendage occlusion (LAAO), have not yet fulfilled their initial promise as safe and effective alternatives.
Authors
- Gunnar Henrik Heine (ORCID: https://orcid.org/0000-0001-8320-5260)
- Wolfgang C. Winkelmayer (ORCID: https://orcid.org/0000-0002-5272-425X)
- An S. De Vriese (ORCID: https://orcid.org/0000-0002-9596-8529)
- Marie Evans (ORCID: https://orcid.org/0000-0001-8650-5795)
- Ingo Eitel (ORCID: https://orcid.org/0000-0002-6442-246X)
- Lukas Urbanek (ORCID: https://orcid.org/0000-0002-5234-744X)
- Caroline Schneppe
Institutions
- Karolinska University Hospital (SE)
- Baylor College of Medicine (US)
- Karolinska Institutet (SE)
- Ghent University (BE)
- Cardiovascular Center Bethanien (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- AZ Sint-Jan (BE)
- KfH Kuratorium für Dialyse und Nierentransplantation (DE)
- Agaplesion Markus Hospital (DE)
- Saarland University (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1093/ndt/gfag263
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00